Professor of Medicine, University Miami School of Medicine
Endocrinology
Dr. Jay S. Skyler, MD
|
|
Give Review
Doctor Jay S. Skyler, MD practices Endocrinology. He graduated from Jefferson Medical College. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Whos Who in Medicine and Healthcare" and "Super Doctor". Skyler is also published. He has 41 publications published. The lastest publication: "The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months.
- A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History.
- Characterizing subgroups of type 1 Diabetes.
- Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 Diabetes.
- Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 Diabetes.
- ATG in type 1 Diabetes: an unanswered question.
- Co-Stimulation Modulation with Abatacept in Patients with Recent-Onset Type 1 Diabetes: Follow-Up One Year After Cessation of Treatment.
- The compelling case for anti-CD3 in type 1 Diabetes.
- B-Lymphocyte Depletion With Rituximab and Beta-Cell Function: Two-Year Results.
- An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.
- The Acceleration of the Loss of the First-Phase Insulin Response during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants.
- Immunotherapy trials for type 1 Diabetes: the contribution of George Eisenbarth.
- Options for Prandial Glucose Management in Type 2 Diabetes Patients Using Basal Insulin: Addition of a Short-acting GLP-1 Analogue versus Progression to Basal-Bolus Th...
- Interleukin-1 antagonism in type 1 Diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
- The year in immune intervention for type 1 Diabetes.
- Primary and secondary prevention of Type 1 Diabetes.
- Innate and adaptive immune gene expression profiles as biomarkers in human type 1 Diabetes.
- Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis.
- The metabolic progression to type 1 Diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.
- The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes.
- Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 Diabetes.
- Stopping type 1 Diabetes: attempts to prevent or cure type 1 Diabetes in man.
- Continuous subcutaneous insulin infusion--an historical perspective.
- Insulin glargine and Cancer--an unsubstantiated allegation.
- Continuous glucose monitoring: an overview of its development.
- CGM--a technology in evolution.
- High-dose insulin therapy: is it time for U-500 insulin?
- Central Obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
- Glucose and C-peptide changes in the perionset period of type 1 Diabetes in the Diabetes Prevention Trial-Type 1.
- Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
- Thirty years of Diabetes care: reflections on the beginning.
- Pulmonary insulin delivery--state of the art 2007.
- Cellular therapy for type 1 Diabetes: has the time come?
- Suppression of human immunodeficiency virus Type 1 viral load with selenium supplementation: a randomized controlled trial.
- Patterns of metabolic progression to type 1 Diabetes in the Diabetes Prevention Trial-Type 1.
- Pulmonary insulin update.
- Effects of oral insulin in relatives of patients with type 1 Diabetes: The Diabetes Prevention Trial--Type 1.
- Diabetes mellitus: pathogenesis and treatment strategies.
- C-peptide is the appropriate outcome measure for type 1 Diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
- HIV, metabolic Syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
Duke University Med Center
Conditions Treated
- Abnormal Thyroid
- Calcium Metabolism Disorders
- Diabetes Mellitus, Secondary
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
- Super Doctor
Education
-
Duke University Hospital -
Jefferson Medical College
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1437114691 | |
| NPPES Provider LastName | SKYLER | |
| NPPES Provider FirstName | JAY | |
| NPPES Provider ZIPCode | 331361011 | |
| NPPES Provider State | FL | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 240.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437114691 |
| Last Name Of The Provider | SKYLER |
| First Name Of The Provider | JAY |
| View All |
Similar Doctors
|
|
Dr. Jay M. Sosenko, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kenneth B. Shephard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan Garces, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcelo V. Bendix, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walid B. Chacra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodolfo A. Alejandro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raquel N. Faradji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara M. Muina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marianne Madiedo, MD
This Doctor is OpenDoctor Recommended.
|